Previous studies have demonstrated an atherogenic lipid and Experimental Medicine, Videnska 1958/9, Prague 4, 140 21, profile (Talbott et al., 1995 (Talbott et al., , 1998 Robinson et al., 1996;  Czech Republic Rajkhowa et al., 1997) and enhanced plasminogen activator 5 To whom correspondence should be addressed inhibitor type 1 (PAI-I) production (Sampson et al., 1996; Atiomo et al., 1998) in PCOS patients. Peripheral insulin The aim of the study was to determine the prevalence of resistance, dyslipidaemia, and increased PAI-I activity are non-insulin dependent diabetes mellitus (NIDDM), arterial important risk factors for cardiovascular disease in these hypertension, coronary artery disease and the risk factors patients. for these diseases in perimenopausal women with a history
In addition to these theoretical considerations, there are only of polycystic ovary syndrome (PCOS) treatment. A group few data confirming an increased risk for certain diseases in of 28 women was selected from a large group of patients PCOS women at a later age. To date, two studies (Dahlgren who had undergone wedge ovarian resection. A total of et al., 1992, 1994) have focused on the risk of arterial 752 controls was selected by age (45-59 years) from a hypertension and NIDDM in women in perimenopausal age random female population sample. There was no difference with a history of PCOS. In a retrospective cohort study, a higher between the two groups in body mass index, waist circumprevalence of NIDDM and hypertension was demonstrated in ference or waist-hip ratio. Both groups were found to have a group of 33 patients previously treated for PCOS, when identical family histories of NIDDM, hypertension, and compared to 132 age-matched controls. In the more recent coronary artery disease and identical smoking habits. We study, a higher prevalence of hypertension and diabetes mellitus did not find a difference between the mean concentrations was shown in a group of 28 PCOS women, aged 43-62 years, of lipids and fasting glucose. The two groups did not matched by age and BMI (body mass index) to 56 controls. differ in the proportions of women with elevated lipid Recently, clinical evidence of an increased risk for atheroconcentrations. The prevalence of NIDDM and coronary sclerosis in women with PCOS was obtained (Guzick et al. , artery disease was significantly higher in PCOS women. 1996). Sixteen women Ͼ40 years of age, with a history of In conclusion, women in the general population have the treatment of PCOS, exhibited significantly greater intima/ same level of risk factors at perimenopausal age as PCOS media thickness and a higher prevalence of plaque measured women. Patients with markedly expressed clinical sympby carotid artery ultrasonography compared to 16 agetoms of PCOS made up a subgroup in the general populamatched controls. tion at high risk for developing NIDDM and coronary
The aim of our study was to evaluate the prevalence of artery disease.
NIDDM, arterial hypertension and coronary artery disease Key words: coronary artery disease/late risks/NIDDM/PCOS (CAD), and the risk factors for these diseases in a group of women aged 45-59 years who had been treated for markedly expressed clinical symptoms of PCOS. This paper was not supported by a commercial company in Introduction any way. Polycystic ovary syndrome (PCOS) is the most frequent endocrine disorder in women, the most common cause of Material and methods anovulatory infertility, oligomenorrhoea and hirsutism. The disorder affects almost 10% of women of fertile age (Yen, Cases 1986 ). However, the exact prevalence is not known, as hyperin-A group of 61 women aged 45-59 years, who had undergone wedge sulinaemia and insulin resistance are characteristic features of ovarian resection in our department shown to have β-cell dysfunction independent of obesity and score Ͼ8), (iii) anovulatory infertility and (iv) typical appearance of by an immunoinhibition method (HDL-C Direct, Wako Chemicals
There were no significant differences between the two groups.
GmbH, Neuss, Germany). mined by the same method after precipitation of serum lipoproteins with sodium phosphotungstate and magnesium chloride (kits There were no significant differences between the two groups.
Controls
from Boehringer Mannheim, Germany). Low density lipoprotein HDL ϭ high density lipoprotein; LDL ϭ low density lipoprotein.
(LDL)-cholesterol was calculated using the Friedewald formula (LDLcholesterol ϭ total cholesterol -HDL cholesterol -triglyceride/ data was identified in all variables except triglycerides and fasting 2.19 mmol/l; Friedewald et al., 1972) .
glucose. Therefore these variables were logarithmically transformed.
A two-way analysis of variance together with Bonferroni's method Clinical investigations of multiple comparison was used to evaluate differences between All women had their family history taken with regard to hypertension, pre-and post-menopausal subgroups. The study was approved by the NIDDM and CAD in their parents. Each patient had her height and Local Ethics Committees. weight taken and her BMI was calculated; waist and hip circumferences were measured in the standing position at the levels of the umbilicus and spina iliaca anterior superior and the waist-hip ratio
Results
(WHR) was calculated. Venous blood samples were drawn from an Although the only criterion for the selection of the control antecubital vein after an overnight fast and glucose, total cholesterol, group was the age range, both the groups did not differ in the HDL-cholesterol and triglyceride concentrations were estimated.
anthropometric parameters assessed (BMI, waist circumferBlood pressure readings were taken twice in the sitting position after ence, WHR) (Table I) . Similarly, there were no differences 10 min rest and the average of both determinations was calculated.
between the two groups in the proportions of obese women Arterial hypertension was defined as a blood pressure ജ140/90 mm Hg at clinical examination or by current use of antihypertensive (BMI Ͼ28.9) and women with an increased WHR (WHR medication. CAD was defined as follows: chest pain evaluated as Ͼ0.85) ( Table II) . The groups did not differ in the incidence definite or possible angina, a history of definite or possible myocardial of NIDDM, hypertension, and CAD in their parents (Table I) .
infarction, a history of transluminal percutaneous coronary angioplasty
The proportions of smokers were almost identical in PCOS (PTCA) or coronary artery bypass grafting (CABG). NIDDM was patients and in the control group (Table II) . women of fertile age has been repeatedly reported in the literature (Lapidus et al., 1984; Talbott et al., 1995) . The *Systolic blood pressure. **Diastolic blood pressure.
volume of visceral fat is an important risk factor for the There were no significant differences between the two groups.
development of cardiovascular disease. Although age range was the only criterion for selecting the control group, our controls did not differ from PCOS women in mean BMI, waist respectively). The fasting glucose concentrations among PCOS circumference and WHR. Our results indicate that, in older and control subjects did not differ significantly. In 33% of age, there is a trend for the difference between PCOS women women of either group, the diagnosis of NIDDM was not and the general population in these anthropometric parameters established until indicated by fasting glucose concentrations to minimize. (ജ7.0 mmol/l). The PCOS and control groups did not differ Only 35.7% of women with a history of PCOS, compared significantly in the proportion of women with fasting glucose to 58.2% in the control group, were post-menopausal concentrations of 6.11-6.99 mmol/l (impaired fasting glucose) (P Ͻ 0.05). This is in agreement with the previous studies (17.6 versus 10.4% respectively). (Dahlgren et al., 1992 (Dahlgren et al., , 1994 . We can speculate that the A comparison of the groups did not reveal a significant number of ovulations during life or an impaired process of difference in the mean serum concentrations with regard to a apoptosis could play a role in determining the age of the single parameter of the lipid profile (Table III) . There was no menopause. difference between the groups of PCOS women and controls It was previously reported that women with PCOS have in the proportion of subjects with elevated total cholesterol higher very low density lipoprotein (VLDL; Robinson et al., (Ͼ5.2 mmol/l) (71.4 versus 71% respectively), LDL-choles-1996) and lower HDL concentrations (Wild et al., 1985) . This terol (Ͼ3.7 mmol/l) (57.1 versus 44.3% respectively), or was later confirmed to be independent of weight (Wild et al., triglycerides (Ͼ1.9 mmol/l) (25 versus 27.5% respectively) 1988). Recently, a large study of 206 women with PCOS (Table II) . At least one parameter of the lipid profile was confirmed higher total cholesterol, LDL-cholesterol and triincreased in 78.6% of PCOS women and in 76.2% of controls.
glycerides, and lower HDL-cholesterol concentrations after While only 35.7% of women in the PCOS group were postadjustment for BMI (Holte et al., 1994) . menopausal, the corresponding value for the control group Compared to controls, there was no difference in the mean was 60.2% (i.e. 433/719, excluding 33 women for whom values of any of the lipid parameters. The proportion of women records not available; see below). There were no significant with elevated lipid concentrations likewise did not differ differences between post-menopausal PCOS women and conbetween the two groups. We thus confirmed the data reported trols in the mean age of menopause (48.7 Ϯ 4.16 versus by a previous elegant study (Talbott et al., 1995) , which found 47.8 Ϯ 4.61 respectively) and the mean number of postthat PCOS women Ͻ40 years of age had substantially higher menopausal years (5.2 Ϯ 2.53 versus 5.5 Ϯ 3.95 respectively).
LDL and total cholesterol concentrations after adjustment for Because of the different proportions of post-menopausal BMI and insulin concentrations, and which observed only women in the two groups, each group was subdivided into minor differences between PCOS women and controls in the pre-and post-menopausal subgroups. A reliable history of Ͼ40 years group. Although there were some methodological menopause was not available in 33 controls; therefore they differences in biochemical assays in our study, both laboratories were excluded from further analysis. Again, no differences were standardized with the Center for Disease Control (Atlanta, were found in anthropometric parameters, mean blood pressure, GA, USA). lipids and fasting glucose between the four tested subgroups One of the parameters possibly determining serum lipid (Table IV) .
concentrations, blood pressure and body fat distribution is The prevalence of NIDDM, hypertension and CAD among decreasing oestrogen production in menopause. Because of the PCOS subjects and controls is shown in Table V . Hypertension unequal proportion of postmenopausal women, each group was diagnosed in 50% of PCOS women and in 39% of controls was subdivided to reflect the history of menopause. Again, (not significant), the diagnosis of NIDDM was established in there were no differences found between the tested subgroups 32% of women with PCOS and in 8% of controls (P Ͻ 0.001), in the above parameters. CAD was diagnosed in 21% of PCOS women and in 5% of An increased prevalence of impaired glucose tolerance and NIDDM in women with PCOS has been demonstrated in many controls (P Ͻ 0.001). Thus, only the difference between the with this expectation, the prevalence of NIDDM, arterial and CAD in our women with a history of PCOS was four times that of a control group representing the Czech female NS ϭ not significant. population. The difference was not statistically significant regarding the incidence of hypertension. One in two women studies (Dunaif et al., 1987; Harris et al., 1987; with PCOS was diagnosed to have hypertension, one in three et al., 1992 Holte et al., 1994) . However, the relative met the criteria of NIDDM and one in five was being treated contribution of insulin resistance and β-cell dysfunction to the for CAD. At the same time, there was no difference between pathogenesis of NIDDM has been controversial; it has been the two groups in the family histories of the diseases studied postulated (Ehrmann, 1997 ) that only women with PCOS who and smoking habits. have an additional defect, such as hypersecretion of insulin,
In conclusion, the group of women with PCOS did not tend to develop NIDDM.
differ from the large control group in their basic anthropometric Some studies showed data confirming an increased risk for criteria (BMI, WHR, waist circumference), family history, or hypertension and CAD in PCOS women. An increased risk proportions of smokers. The identical lipid profiles between for arterial hypertension in women with a history of PCOS at these groups were most probably the consequence of a deteriorolder age has been repeatedly demonstrated (Dahlgren et al., ating status in a population of older age. Despite the identical 1992, 1994). Higher daytime systolic arterial mean blood risk for the development of the diseases studied, the prevalence pressure, which persisted after adjustment for BMI, insulin of NIDDM and CAD was significantly higher in PCOS women. sensitivity and body fat distribution, in women with PCOS of Our results confirm that women with markedly expressed fertile age has also been documented (Holte et al., 1996) .
clinical symptoms of PCOS make up a subgroup in the general A New Zealand study demonstrated a high prevalence of population, at high risk for the development of NIDDM sonographically verified polycystic ovaries in women with and CAD. documented coronary artery disease (CAD) (White et al., 1994) . A higher incidence of hirsutism in women with CAD compared to women without this finding was demonstrated using coronary arteriography (Wild et al., 1990) .
